Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Ovarian Cancer
1 other identifier
observational
300
1 country
1
Brief Summary
The relationship between immune inflammation-related protein complexes inblood and recurrence or metastasis of ovarian cancer will be studied
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 3, 2022
CompletedFirst Submitted
Initial submission to the registry
June 4, 2022
CompletedFirst Posted
Study publicly available on registry
June 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 3, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 3, 2026
CompletedJune 8, 2022
March 1, 2022
2 years
June 4, 2022
June 4, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Immune Inflammation-Related Protein Pomplexes
The change of immune inflammation-related protein complexes
2 years
Interventions
Normal clinical treatment without intervention
Eligibility Criteria
The study population included normal ovarian controls, patients with benign ovarian disease, and patients with malignant epithelial ovarian cancer.
You may qualify if:
- Female
- Normal ovary control
- Ovarian benign disease
- Ovarian malignant epithelial carcinoma
You may not qualify if:
- Male
- Age above 70
- Suffering from other malignant tumors
- Non-compliant patient
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Biospecimen
1 mL of serum
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 4, 2022
First Posted
June 8, 2022
Study Start
February 3, 2022
Primary Completion
February 3, 2024
Study Completion
February 3, 2026
Last Updated
June 8, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share